Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat

Background: Roxadustat is a new oral drug for anemia in chronic kidney disease (CKD). This study aimed to synthesize the evidence from randomized controlled trial (RCT)-based studies that estimated the efficacy and safety of roxadustat in anemia patients with non-dialysis-dependent (NDD) and dialysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Mei, Zhu, Changyu, Yan, Ting, Zhou, Yanglin, Lv, Qin, Chuan, Junlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283176/
https://www.ncbi.nlm.nih.gov/pubmed/34276361
http://dx.doi.org/10.3389/fphar.2021.658079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283176/
https://www.ncbi.nlm.nih.gov/pubmed/34276361
http://dx.doi.org/10.3389/fphar.2021.658079

Ejemplares similares